Crinetics Pharmaceuticals Non-Current Portion of LTD and Capital Lease Obligation (Annual) Analysis

Crinetics Pharmaceuticals, Inc. (CRNX)

54.95 -0.46 (-0.83%) USD | NASDAQ | Jan 22, 16:00

54.95 0.00 (0.00%) Pre-Market: 09:09

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) for CRNX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) Benchmarks

Start Trial

Madrigal Pharmaceuticals, Inc.	Upgrade
GT Biopharma, Inc.	--
Axsome Therapeutics, Inc.	Upgrade
Sutro Biopharma, Inc.	Upgrade
Gossamer Bio, Inc.	Upgrade